A Study to Assess the Effect of a Strong CYP3A Inhibitor, on Surufatinib in Healthy Subjects

NCT04372407 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Surufatinib
DRUG: Itraconazole

Sponsor

Hutchison Medipharma Limited